SI-BONE Inc. (SIBN) Tops Q3 EPS by 9c, offers guidance

SI-BONE Inc. (NASDAQ: SIBN) reported Q3 EPS of ($0.25), $0.09 better than the analyst estimate of ($0.34). Revenue for the quarter came in at $34 million versus the consensus estimate of $32.38 million.

2023 Updated Financial Guidance:

Based on the strength of the Company's year-to-date performance, and the momentum exiting the third quarter of 2023, SI-BONE is increasing its 2023 worldwide revenue guidance to be in the range of $136 million to $137 million from the previous guidance of $132 million to $134 million. The updated guidance translates to growth of approximately 28% to 29% compared to fiscal year 2022, versus the previous revenue growth of approximately 24% to 26%.

For earnings history and earnings-related data on SI-BONE Inc. (SIBN) click here.

You May Also Be Interested In

• Star Equity Holdings (STRR) Misses Q2 EPS by 8c
• Calidi Biotherapeutics (CLDI) Reports Q2 Loss of $2.94
• Instil Bio Inc. (TIL) Misses Q2 EPS by 21c